Home » Newsletters » BioWorld

BioWorld

May 22, 1995

View Archived Issues

OTHER NEWS TO NOTE

BIOCRYST RAISES $8.5M IN SALE OF 1.54M SHARES

GENZYME, IG LABS AGREE TO TERMS OF BUYOUT

CHIRON SAYS PHASE II DATA POSITIVE ON PROLEUKIN FOR OVARIAN CANCER

SHAMAN SIGNS DEAL WITH ONO, DELAYS PHASE II RSV TRIAL

SCRIPTGEN RAISES $6.6M IN SECOND ROUND OF FINANCING

LTI SAYS DOXIL BETTER IN KAPOSI'S SARCOMA THAN CHEMOTHERAPY REGIMEN

JAPANESE ONCOLOGISTS FIND DNA TESTING BEATS MICROSCOPE FOR CANCER

TALK OF FDA REFORM ON BIO'S AGENDA FOR ANNUAL MEETING

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026